Back to Search
Start Over
Alto Neuroscience initiates Phase 2 study of ALTO-101
- Source :
- The Fly. June 20, 2024
- Publication Year :
- 2024
-
Abstract
- Alto Neuroscience announced the initiation of a Phase 2 double-blind, placebo-controlled study of its transdermal formulation of ALTO-101, a novel PDE4 inhibitor in development for the treatment of cognitive impairment [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.798398343